Advanced BioMedical Technologies, Inc. Stock-Based Compensation
Advanced BioMedical Technologies, Inc. reported Stock-Based Compensation of -$3.73 thousand for the 3-month period ending 2021-07-31, per its 10-Q filed 2021-09-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-09-13
- Advanced BioMedical Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-07-31 was -$3.73K, a 184.80% decline year-over-year.
- Advanced BioMedical Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-04-30 was -$18.00, a 100.28% decline year-over-year.
- Advanced BioMedical Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-01-31 was $4.54K.
- Advanced BioMedical Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-10-31 was $39.74K.
- Advanced BioMedical Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $50.61K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2021-07-31 | -$3.73K 10-Q · filed 2021-09-13 | -$3.75K derived: sum of 2 quarters · filed 2021-09-13 | $793.00 10-Q · filed 2021-09-13 | $40.54K derived: sum of 4 quarters · filed 2021-09-13 |
| 2021-04-30 | -$18.00 10-Q · filed 2021-06-21 | $4.52K 10-Q · filed 2021-06-21 | $44.27K derived: sum of 3 quarters · filed 2021-06-21 | $48.67K derived: sum of 4 quarters · filed 2021-09-13 |
| 2021-01-31 | $4.54K 10-Q · filed 2021-03-22 | $44.28K derived: sum of 2 quarters · filed 2021-03-22 | $48.69K derived: sum of 3 quarters · filed 2021-09-13 | $55.15K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-10-31 | $39.74K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-29 | $44.14K derived: sum of 2 quarters · filed 2021-09-13 | $50.61K derived: sum of 3 quarters · filed 2021-09-13 | $50.61K 10-K · filed 2021-01-29 |
| 2020-07-31 | $4.40K 10-Q · filed 2021-09-13 | $10.87K derived: sum of 2 quarters · filed 2021-09-13 | $10.87K 10-Q · filed 2021-09-13 | |
| 2020-04-30 | $6.47K 10-Q · filed 2021-06-21 | $6.47K 10-Q · filed 2021-06-21 |